Carotid Ultrasound & Stroke Risk Screening in China

Stroke is the second leading cause of death worldwide and a leading cause of long-term disability. A significant proportion of strokes — particularly ischaemic strokes — are preceded by detectable changes in the carotid arteries that develop silently over years. Carotid ultrasound is a non-invasive, radiation-free imaging test that can identify those changes before a clinical event occurs. For foreigners considering health screening in China, carotid artery assessment is a standard component of the cardiovascular screening panel — offered as part of the SinoCareLink Cardiovascular Health Screening package.

What Carotid Ultrasound Measures

The carotid arteries run up both sides of the neck and supply blood to the brain. A carotid ultrasound uses high-frequency sound waves to produce real-time images of these vessels. The examination measures several things:

Intima-media thickness (IMT)
The intima and media are the two innermost layers of the artery wall. As atherosclerosis develops, these layers thicken. IMT measurement is a validated, reproducible marker of subclinical cardiovascular disease — it correlates with coronary artery disease risk and is used in research and clinical risk stratification worldwide. An elevated IMT in a person without known heart disease is a signal to intensify risk-factor management.

Plaque detection and characterisation
Atherosclerotic plaque — deposits of lipid, inflammatory cells, calcium, and fibrous tissue — builds up in the carotid arteries over time. Ultrasound can detect plaque, estimate its size, and characterise its texture. Soft (lipid-rich) plaques carry a higher risk of rupture and embolism to the brain; calcified plaques are more stable but indicate advanced disease. The degree of stenosis (narrowing of the lumen) caused by plaque is also quantified.

Blood flow assessment (Doppler)
Colour-flow Doppler imaging measures blood velocity through the vessel. Significant stenosis causes turbulent, high-velocity flow — a pattern that indicates haemodynamically significant narrowing that may warrant specialist review.

Vertebral arteries
Many carotid ultrasound protocols also assess the vertebral arteries, which supply the posterior circulation of the brain. Vertebral artery flow abnormalities can contribute to posterior-circulation transient ischaemic attacks (TIAs) and stroke.

Who Should Get Carotid Ultrasound Screening

Carotid ultrasound is relevant for a wide range of adults. The following groups have the strongest reason to consider it:

• Adults aged 45 and above with at least one major cardiovascular risk factor (hypertension, dyslipidaemia, diabetes, smoking, obesity, family history of early cardiovascular disease)
• Adults with known high cardiovascular risk regardless of age — for example, those with a calculated 10-year CVD risk above 10% by Framingham, SCORE2, or QRISK3
• Patients with hypertension — high blood pressure is the single strongest modifiable risk factor for stroke and directly damages arterial walls
• Patients with type 2 diabetes — metabolic disease accelerates atherosclerosis systemically
• Current or former smokers — smoking promotes endothelial dysfunction and plaque formation throughout the arterial tree
• Patients with known or suspected dyslipidaemia, especially elevated LDL or lipoprotein(a)
• Patients who have experienced a TIA — a "mini-stroke" — where carotid stenosis needs to be urgently ruled out as the cause
• Anyone with a cardiac murmur or bruit (noise) detected over the carotid area on routine auscultation
• Patients with a family history of stroke at a relatively young age in a first-degree relative
• Patients with known coronary artery disease — atherosclerosis is a systemic disease; if coronary arteries are affected, carotid arteries frequently are too

Guidelines from the American Heart Association (AHA) and the European Society of Cardiology (ESC) support carotid IMT measurement and plaque assessment as tools for cardiovascular risk stratification in intermediate-risk patients where it may change clinical management.

Carotid Ultrasound in the Context of a Full Cardiovascular Panel

Carotid ultrasound findings are most clinically useful when interpreted alongside other cardiovascular data. An elevated carotid IMT in a person with controlled blood pressure, normal lipids, and no cardiac symptoms has different implications than the same IMT finding in someone with poorly controlled hypertension and borderline ECG changes.

This is why the carotid ultrasound is one component — not a standalone test — within the SinoCareLink cardiovascular screening package. In the same visit, the package includes a resting ECG, echocardiogram, non-invasive arterial stiffness testing, a cardiac and lipid blood panel (~19 markers), and coronary CT angiography (CCTA) where indicated. The reporting physician interprets all of these together, so findings in one modality inform the interpretation of others.

Why Get Stroke Risk Screening Done in China

Accessibility: In the UK, carotid ultrasound is typically available through a specialist referral — it is not a test a GP can routinely order for preventive screening. In the US, self-pay carotid ultrasound is available but rarely part of a coordinated preventive cardiology panel without a physician referral and prior authorisation. In China's health-check centres, carotid ultrasound is a standard item in cardiovascular screening packages with no referral needed.

Cost: Private carotid ultrasound in the UK typically costs £150–£350 as a standalone test. When bundled with echo, ECG, blood panel, and arterial stiffness testing, the equivalent multi-test panel in a private UK or US setting would likely exceed £800–£1,200+. The SinoCareLink cardiovascular package covers all of this at $399 — a substantial difference.

Turnaround: In Chinese health-check facilities, the carotid ultrasound is performed on the same day as the rest of the panel, with the report typically ready within one to three business days. There is no waiting list for preventive assessment.

Equipment and operator volume: Carotid IMT measurement requires a skilled sonographer and modern equipment to be reproducible and clinically meaningful. High-volume health-check centres in China perform these studies in large numbers, and the equipment is routinely calibrated for IMT protocols.

How the Process Works with SinoCareLink

SinoCareLink coordinates your appointment and provides on-the-ground support; it is not itself a medical provider.

1. Inquiry: Through the contact page or WhatsApp, you provide your health background — relevant risk factors, current medications, any prior vascular studies — and your travel dates. This helps SinoCareLink select the most appropriate facility and confirm that carotid ultrasound with IMT reporting is included.

2. Booking: SinoCareLink arranges the appointment and confirms the protocol. If you want a specific city — Beijing, Shanghai, Shenzhen, Guangzhou — or have preferences about facility type (private health-check centre vs. hospital screening unit), these are factored in.

3. Pre-visit preparation: Carotid ultrasound itself requires no fasting. The blood panel component does (8–10 hours fasting). You receive written instructions in advance. Wear clothing with a loose or open collar on the day.

4. The visit: A SinoCareLink coordinator or interpreter accompanies you through the facility. The carotid ultrasound takes approximately 15–25 minutes. You lie on an examination table while the sonographer applies gel and scans both sides of your neck. The procedure is entirely painless.

5. Report and follow-up: The ultrasound findings are incorporated into the consolidated English-language report. If significant stenosis or plaque is found, the report will indicate the degree and recommended next step — typically a specialist consultation with a vascular neurologist or cardiologist. SinoCareLink can coordinate that appointment during your stay or prepare a summary for your home physician.

Frequently Asked Questions

Is carotid ultrasound painful or uncomfortable?
No. It is the same technology used for obstetric scans — a probe with gel applied to the neck, with no radiation or needles involved. Most patients find it completely comfortable.

How is carotid IMT reported, and what does an abnormal result mean?
IMT is typically reported in millimetres, with age- and sex-specific reference ranges. Values above the 75th or 90th percentile for age and sex, or the presence of any plaque, are considered elevated and flag a higher cardiovascular risk. An abnormal result is not a diagnosis — it is a signal to intensify risk-factor management and potentially undertake further investigation.

Can carotid ultrasound directly prevent a stroke?
The test itself does not prevent anything — it identifies risk. What it enables is early intervention: tighter blood pressure control, statin therapy, antiplatelet therapy in appropriate patients, or lifestyle modification. The clinical value is detecting disease before a stroke occurs so that preventive measures can be intensified.

Does this screening detect all types of stroke risk?
Carotid atherosclerosis accounts for a significant proportion of ischaemic stroke risk, but not all. Cardioembolic strokes (from atrial fibrillation, for example) are detected by ECG and echocardiogram — also included in the package. Small-vessel disease and haemorrhagic stroke have different mechanisms. The cardiovascular panel together covers the major detectable risk factors.

How often should carotid ultrasound be repeated?
There is no single universal guideline. If the initial study is normal and risk factors are well-controlled, many clinicians suggest repeating every three to five years. If plaque is found or IMT is elevated, annual or biennial monitoring may be recommended depending on the clinical picture.

Do I need to stop any medications before the test?
In general, no — continue all regular medications. Carotid ultrasound does not require medication adjustment. If you are on anticoagulants, blood thinners, or have specific medication concerns, note this in your intake form.